Atlas market file · Equity · United States
Claritev CorpCTEV
- Last close
- 26.84
- Change
- +2.72%
- 96-bar range
- 11.5 – 35.6
- As of
- 6 Aug 2026
Claritev Corp is a services-business services, nec issuer listed as CTEV on NYSE. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 104 weekly closes (+163.14% over the window).
Source rail: Yahoo Finance chart API (CTEV). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for CTEV. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
CTEV public profile
Services-business services, nec issuer. Claritev Corp is connected to current market context, cited company sources and its retained research file.
Claritev Corp trades as CTEV on NYSE. Claritev Corp (CTEV) has a latest verified close of 26.84, up 2.72%, dated 6 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files CTEV under USA Stocks for browsing.
What changed for Claritev Corp today
Claritev Corp’s latest 10-Q lands with a jolt: revenue of $244.7 million, paired with a $73.6 million net loss and negative $45.8 million in operating cash for the quarter ended 31 March 2026. The balance sheet reads like a cautionary tale-$4.84 billion of assets against $5.07 billion of liabilities, leaving shareholders with a $241.1 million equity deficit and only $21.3 million in cash on hand. The numbers are filed, audited, and undeniably real, yet they sit awkwardly next to the company’s polished pitch about ‘responsible AI’ and ‘connected payment integrity ecosystems.’ The gap between the platform story and the balance sheet is now wider than the deficit in shareholders’ equity. (source: 10-Q period ending 2026-03-31, https://www.sec.gov/Archives/edgar/data/1793229/000179322926000059/ctev-10q_20260331.htm)
Claritev describes itself as a technology, data, and insights company focused on making healthcare more affordable and transparent, and Everest Group’s 2026 PEAK Matrix® assessment places it among the leaders in pre-payment integrity solutions. The accolade comes with a press pack of clinical expertise, trusted solutions, and responsible AI, all framed as a ‘connected payment integrity ecosystem.’ The problem is that the operating numbers tell a different story. The latest 10-Q shows the company burning $45.8 million in operating cash while spending $46.8 million on property, plant, and equipment-hardly the capital allocation profile one expects from a sector leader. Either the matrix is measuring something other than cash economics, or the economics are out of step with the marketing. (source: Everest Group assessment, https://www.claritev.com/newsroom/claritev-rises-to-leader-ranking-in-everest-groups-2026-pre-payment-integrity-solutions-peak-matrix-assessment/; 10-Q period ending 2026-03-31, https://www.sec.gov/Archives/edgar/data/1793229/000179322926000059/ctev-10q_20260331.htm)
The company’s professional-services page promises to ‘sustain, modernise, and implement healthcare technology’ for health plans, accompanied by stock images of confident consultants and clean user interfaces. The claim sounds like a growth story, yet the latest filings show a firm that is haemorrhaging cash, reporting negative $73.6 million in net income and negative $45.8 million in operating cash. The disconnect between the product promise and the cash reality is now structural. Claritev’s financial-negotiation and surprise-bill services may be technically excellent, but the operating cash haemorrhage is the overriding fact in the latest 10-Q. (source: Healthcare Consulting Services for Health Plans, https://www.claritev.com/solutions/professional-services/; Surprise Bill Services, https://www.claritev.com/solutions/claims-intelligence-solutions/surprise-bill-services/; Financial Negotiations, https://www.claritev.com/solutions/claims-intelligence-solutions/negotiation-services/financial-negotiations/; 10-Q period ending 2026-03-31, https://www.sec.gov/Archives/edgar/data/1793229/000179322926000059/ctev-10q_20260331.htm)
The company’s four most recent Form 4 filings-spanning 19 May, 10 June, 22 June, and 2 July 2026-show directors and officers transacting in small lots, but the cumulative effect is modest against a $241.1 million equity deficit. The insider activity reads less like conviction and more like routine housekeeping when the balance sheet is technically insolvent. Claritev’s shareholder deficit is not a forecast; it is a filed reality, and the insider filings do not materially alter the arithmetic. (source: Form 4 filings 2026-05-19, 2026-06-10, 2026-06-22, 2026-07-02, https://www.sec.gov/Archives/edgar/browse/?CIK=1793229)
For readers chasing the gap between the Everest Group narrative and the 10-Q numbers, the next milestone is the company’s next 10-Q or 8-K. If the operating cash burn narrows materially, if the net loss shrinks, or if the balance-sheet deficit stabilises, the story changes. Until then, the equity story is a deficit story told in filed numbers rather than marketing copy. There is no chart that can dress up a $241.1 million equity hole; the facts are already on the public record. (source: 10-Q period ending 2026-03-31, https://www.sec.gov/Archives/edgar/data/1793229/000179322926000059/ctev-10q_20260331.htm; SEC filings index, https://www.sec.gov/edgar/browse/?CIK=1793229)
What remains unproven is whether the gap between the platform story and the cash reality is temporary operational noise or structural misalignment. Claritev’s claim to be a leader in pre-payment integrity depends on more than a third-party ranking; it depends on the company’s ability to convert revenue into operating cash and shrink a $241.1 million equity deficit. The evidence so far is filed, not fixed. (source: Everest Group assessment, https://www.claritev.com/newsroom/claritev-rises-to-leader-ranking-in-everest-groups-2026-pre-payment-integrity-solutions-peak-matrix-assessment/; 10-Q period ending 2026-03-31, https://www.sec.gov/Archives/edgar/data/1793229/000179322926000059/ctev-10q_20260331.htm)
Sources & evidence · 10 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
CTEV technical readout
Directional bias down. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on CTEV
FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep CTEV research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
CTEV FAQ
What is Claritev Corp (CTEV)?Claritev Corp (CTEV) has a latest verified close of 26.84, up 2.72%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates,...
Claritev Corp (CTEV) has a latest verified close of 26.84, up 2.72%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for CTEV?Claritev Corp (CTEV) has a latest verified close of 26.84, up 2.72%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and...
Claritev Corp (CTEV) has a latest verified close of 26.84, up 2.72%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files CTEV under USA Stocks for browsing.
How often is the CTEV page updated?The CTEV public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The CTEV public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for CTEV?The CTEV file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NYSE:CTEV. SEC EDGAR provides the filing anchor for this issuer. The page separates verified...
The CTEV file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NYSE:CTEV. SEC EDGAR provides the filing anchor for this issuer. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on CTEV?Yes. The workstation can open CTEV, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open CTEV, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this CTEV page investment advice?No. The CTEV page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The CTEV page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →
CTEV
Equity · evidence first